openPR Logo
Press release

SNP Genotyping and Analysis Market to Expand at a Robust 21.8% CAGR by 2019

07-11-2018 01:56 PM CET | Health & Medicine

Press release from: Transparency Market Research

SNP Genotyping and Analysis Market to Expand at a Robust 21.8%

Due to the existence of a large number of players in domestic markets and few leaders at the global level, the global SNP genotyping and analysis market sees intense competition in two distinct arenas. Global players are entering into long-term contracts with hospitals to ensure that they have access to a captive market. This strategy has also proven useful in consolidating their position at the regional level. The top three companies, Life Technologies, Illumina Inc., and Affymetrix held approximately 66.4% of the global market in terms of revenue in the 2012

Moreover, with large companies entering into long term contracts with hospitals, smaller companies are focusing on the upgradation of their portfolio and competitive pricing to stay both relevant and competitive.

Obtain Report Details @ https://www.transparencymarketresearch.com/snp-single-nucleotide-polymorphism-market.html

Rising Demand from Breeding and Livestock Sector to Drive Demand for Genotyping Market

International organizations such as the WHO and UN Food and Agriculture Organization have recorded an increase in the level of meat and dairy consumption worldwide. There has been a considerable rise in meat consumptionin countries such as India where the population of vegetarians is more in comparison to non-vegetarians. . The rise in demand for meat has compelled researchers and institutions to invest in research and development activities to maintain a certain level of hygiene in meat and dairy products. The hygiene level can be maintained in meat and dairy products by a regular SNP analysis of animal livestock. The rise in this activity is expected to drive the demand for SNP genotyping in the upcoming years.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=432

Lack of Reimbursement Policies to Hamper Adoption of SNP Genotyping

The average cost of genotyping and DNA sequencing test is reported to be between US$1,000 and US$3,000. Moreover, insurance policies do not cover the expenses occurred by the patients for these tests, making them unaffordable for many people. The lack of proper reimbursement policies will thus hinder the market growth. The pending approvals by the FDA due to a lack of evidence for proving the tests’ accuracy is also likely to hinder the market growth.

Players in the global SNP genotyping and analysis market are anticipated to gain opportunities in developed and developing countries due to the increasing demand for affordable genotyping services. As a result of this, companies are working towards decreasing the cost of sequencing making it fall within the reach of the average consumer. The increasing awareness among consumers to understand their genetic makeup s projected to provide future growth prospects to market players.

However, imperfect tools and protocols resulting in large redundant data and inaccurate results can hamper the market growth to some extent.

In spite of all these factors, the global SNP genotyping and analysis market is projected to grow at a CAGR of 21.80% between 2013 and 2019. The global SNP genotyping and analysis market is estimated to reach US$9.48 bn by the end of 2019 from a market worth US$4.30 bn in 2015. Asia Pacific is projected to witness the highest growth by 2019 with a CAGR of 23.1%. The diagnostics application segment is expected to maintain its lead in the market with an overall global share of 22.7% by 2019.

Enquiry for Discount on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=432

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SNP Genotyping and Analysis Market to Expand at a Robust 21.8% CAGR by 2019 here

News-ID: 1120566 • Views:

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights and
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughs
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examine

All 5 Releases


More Releases for SNP

The Rising Role Of SNP Genotyping In Chronic Disease Management: Strategic Insig …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Single Nucleotide Polymorphism (SNP) Genotyping Market Size By 2025? The market dealing with single nucleotide polymorphism (snp) genotyping has experienced substantial expansion recently; projections indicate a rise from a valuation of $10.3 billion in 2024 to $12.34 billion in 2025, reflecting a robust compound annual
SNP Genotyping Market to Reach USD 39.2 Bn by 2034
Introduction Single nucleotide polymorphisms (SNPs) are the most common form of genetic variation, occurring once in every 300 nucleotides on average. SNP genotyping has become a cornerstone of genomics, enabling researchers and clinicians to identify genetic predispositions, understand disease mechanisms, develop targeted therapies, and improve crop and livestock breeding. The integration of high-throughput technologies, falling sequencing costs, and rising demand for personalized medicine are fueling market growth. By 2024, the SNP genotyping
Booming SNP Genotyping Market: Rapid Growth, Major Players, and Emerging Trends
"The global single nucleotide polymorphism genotyping market showcases a robust growth rate powered by advancements and increasing demand in the field. What Is The Projected Market Size Of The Global Single Nucleotide Polymorphism (SNP) Genotyping Market And Its Growth Rate? The SNP genotyping market size has experienced rapid growth in recent years and is projected to continue this trend. Differences in data are as follows: • Growth from $10.3 billion in 2024 to
SNP genotyping Market 2023 Driving Factors Forecast Research 2029
SNP genotyping market is anticipated to grow at a significant CAGR of 20.5% during the forecast period. The market is mainly driven by increasing R&D projects in genotyping domain, and rising funding in the biotechnology industry. The biopharmaceutical companies are investing heavily in the R&D projects, attributed to advances and discoveries. From genomics to personalized medicines, all the recent advancement has created significant scope in developing unique treatment options for
SNP genotyping Market Outlook 2029: Presents Market Insights & Depth Analysis
The global SNP Genotyping market is anticipated to grow at a CAGR of 20.5% during the forecast period (2023-2030). Genotyping detects tiny differences in genetic sequence within populations such as single-nucleotide polymorphisms (SNPs). SNP technology is used to study the genetic elements of complex diseases. SNPs are markers that are utilized in different human ailments and are employed in pharmacogenomics to provide medicine according to the need. Thus, the rising
Explore Single Nucleotide Polymorphism (SNP) Genotyping Market Demand 2020 - 202 …
According to a new report published by Allied Market Research, titled, "World Single Nucleotide Polymorphism (SNP) Genotyping Market - Opportunities and Forecasts, 2019-2026" The global market size of Single Nucleotide Polymorphism (SNP) Genotyping is $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end of 2026 with a CAGR of XX% from 2020 to 2027. Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/1464?utm_source=openpr&utm_medium=Niranjan Key